Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin-10 and its receptor

A S Ho1, K W Moore

  • 1Department of Immunology, DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA 94306, USA.

Therapeutic Immunology
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Re-examining post-operative chemoradiotherapy in head and neck cancer: an updated long-term combined analysis of RTOG 9501/EORTC 22931.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Quantitative lymph node burden as a 'very-high-risk' factor identifying head and neck cancer patients benefiting from postoperative chemoradiation.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

Quantitative lymph node burden as a 'very-high-risk' factor identifying head and neck cancer patients benefiting from postoperative chemoradiation.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Reply to: Radioiodine ablation necessary for patients with low-risk papillary thyroid carcinoma and tumor >4 cm?

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2017
Same author

Selective use of radioactive iodine (RAI) in thyroid cancer: No longer "one size fits all".

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2017
Same author

Antiviral, cyototoxic and antimicrobial activities of anthraquinones isolated from the roots of morinda elliptica.

Pharmaceutical biology·2011
Same journal

Rational development of tumour antigen-specific immunization in melanoma.

Therapeutic immunology·1995
Same journal

Potential use of in vitro anterior chamber-associated immune deviation (ACAID) for the immunotherapeutic prevention of autoimmune disease and graft rejection.

Therapeutic immunology·1995
Same journal

The development of anti-CD79 monoclonal antibodies for treatment of B-cell neoplastic disease.

Therapeutic immunology·1995
Same journal

Ex-vivo whole blood cultures for predicting cytokine-release syndrome: dependence on target antigen and antibody isotype.

Therapeutic immunology·1995
Same journal

Cytotoxic lymphocytes: redirecting the cell-mediated immune response for the therapy of cancer.

Therapeutic immunology·1995
Same journal

Immunomodulation by LFA3TIP, an LFA-3/IgG1 fusion protein: cell line dependent glycosylation effects on pharmacokinetics and pharmacodynamic markers.

Therapeutic immunology·1995
See all related articles

Interleukin-10 (IL-10) is a crucial immune regulator, impacting macrophage activation and B and T cell proliferation. Viral IL-10 from Epstein-Barr virus (EBV) mimics these functions, potentially influencing host-virus interactions.

Area of Science:

  • Immunology
  • Molecular Biology
  • Virology

Background:

  • Interleukin-10 (IL-10) is a key cytokine with diverse effects on immune cells.
  • IL-10 significantly modulates macrophage activation and antigen presentation.
  • It also influences the proliferation and differentiation of B cells and T cells.

Purpose of the Study:

  • To review recent findings on the functions of IL-10.
  • To discuss the initial characterization of the IL-10 receptor.
  • To explore the role of viral IL-10 homologs in host-virus relationships.

Main Methods:

  • Literature review of recent studies on IL-10.
  • Analysis of the biological activities of IL-10.
  • Review of research on the IL-10 receptor.

Related Experiment Videos

Main Results:

  • IL-10 suppresses macrophage activation, cytokine secretion, and accessory cell function.
  • IL-10 promotes proliferation and differentiation in B cells, mast cells, and T cells.
  • Epstein-Barr virus (EBV) encodes a viral IL-10 (vIL-10) with similar activities.

Conclusions:

  • IL-10 is a pleiotropic cytokine with critical roles in immune regulation.
  • Viral IL-10 may play a significant role in the pathogenesis of EBV infections.
  • Further research into the IL-10 receptor is warranted.